In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Latest From PsychoGenics Inc.

Deal Watch: Aging-Focused Calico Taps Start-Up Terray For Discovery

Terray/Calico tie-up will focus on small molecule discovery for diseases of aging, including cancer. Lilly, AstraZeneca sign discovery pacts with Nimbus and Illumina, respectively.

Deal Watch Business Strategies

Deal Watch: AbbVie Exits Inherited CRISPR-Cas9 Team-Up With Editas

Editas regains rights to ocular programs first partnered with Allergan in 2017. Newly public F-star will focus on bispecific antibodies for cancer, TriSalus acquires oncology candidate from Dynavax.

Deals Business Strategies

Sunovion’s TAAR1 Agonist Brings Something New To CNS Arena

Sunovion’s new schizophrenia candidate is generating investor attention given its first-in-class mode of action. Newly published clinical results appear to bear out its promise in a sector where there’s been limited innovation.

Neurology Clinical Trials

Dainippon Lays Out R&D Table Ahead Of Latuda Challenges

Vant deal, discovery platforms help Japanese firm build out pipeline before it faces the first expiries for its top seller.

Clinical Trials Innovation
See All

Company Information

  • Industry
  • Contract Research, Toxicology Testing-CRO
  • Pharmaceuticals
  • Services
  • Biotechnology
    • Transgenics
    • Drug Discovery Tools
      • ADMET
      • Bioinformatics
      • Genomics-Proteomics
UsernamePublicRestriction

Register